Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00531713Phase 4Completed
Phase 4, randomised, double-blind trial of liothyronine in hypothyroidism (2 arms), sponsored by Rigshospitalet. Primary endpoints: Short Form-36 Health Survey at 3 months, Symptom Checklist-90-Revised at 3 months and 1 more. Started Apr 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00531713.